New product expansion Proveris recently expanded its product portfolio with the vereo NSx+SWC Nasal Spray System for Delivered Dose Uniformity testing, signaling a growing scope in OINDP testing capabilities and opportunities to upsell enhanced testing solutions and service packages.

Growing OINDP focus Specialization in orally inhaled and nasal drug products (OINDPs) positions Proveris to target pharma manufacturers and CDMOs investing in inhalation therapies, with potential to partner across development stages from formulation to device selection and QA testing.

Laboratory expertise With extensive in-house laboratory testing and collaboration with industry influencers, Proveris offers unique processes and data-driven insights, enabling a compelling value proposition for customers seeking robust testing strategies and instrument provisioning.

Regulatory alignment Proveris emphasizes FDA and ICH guideline alignment through its Proveris by Design process, suggesting opportunities to support clients seeking compliant testing strategies, method development, and regulatory-ready data generation.

Strategic hires Recent talent acquisitions and leadership appointments in research and business development indicate a ramp-up in capabilities and client-facing capacity, enabling expanded outreach and larger multi-year contracts.